RFI-641, a Potent Respiratory Syncytial Virus Inhibitor

Human respiratory syncytial virus (RSV), a paramyxovirus, is a major cause of acute upper and lower respiratory tract infections in infants, young children, and adults. RFI-641 is a novel anti-RSV agent with potent in vitro and in vivo activity. RFI-641 is active against both RSV type A and B strain...

Descripción completa

Guardado en:

Detalles Bibliográficos
Publicado en:	Antimicrob Agents Chemother
Autores principales:	Huntley, Clayton C., Weiss, William J., Gazumyan, Anna, Buklan, Aron, Feld, Boris, Hu, William, Jones, Thomas R., Murphy, Timothy, Nikitenko, Antonia A., O'Hara, Bryan, Prince, Gregory, Quartuccio, Susan, Raifeld, Yuri E., Wyde, Philip, O'Connell, John F.
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 2002
Materias:	Antiviral Agents
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127488/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11850270/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.3.841-847.2002
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

RFI-641, a Potent Respiratory Syncytial Virus Inhibitor

Ejemplares similares